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Non-O157 Shiga toxin-producing Escherichia coli (STEC) strains are clinically significant food-borne patho-
gens. However, there is a dearth of information on serotype prevalence and virulence gene distribution, data
essential for the development of public health protection monitoring and control activities for the meat and
dairy industries. Thus, the objective of this study was to examine the prevalence of non-O157 STEC on beef and
dairy farms and to characterize the isolates in terms of serotype and virulence markers. Bovine fecal samples
(n  1,200) and farm soil samples (n  600) were collected from 20 farms throughout Ireland over a 12-month
period. Shiga toxin-positive samples were cultured and colonies examined for the presence of stx1 and/or stx2
genes by PCR. Positive isolates were serotyped and examined for a range of virulence factors, including eaeA,
hlyA, tir, espA, espB, katP, espP, etpD, saa, sab, toxB, iha, lpfAO157/OI-141, lpfAO113, and lpfAO157/OI-154. Shiga toxin
and intimin genes were further examined for known variants. Significant numbers of fecal (40%) and soil (27%)
samples were stx positive, with a surge observed in late summer-early autumn. One hundred seven STEC
isolates were recovered, representing 17 serotypes. O26:H11 and O145:H28 were the most clinically significant,
with O113:H4 being the most frequently isolated. However, O2:H27, O13/O15:H2, and ONT:H27 also carried
stx1 and/or stx2 and eaeA and may be emerging pathogens.
Shiga toxin-producing Escherichia coli (STEC), also referred
to as verocytotoxogenic Escherichia coli (VTEC), has emerged
as a group of highly pathogenic Escherichia coli strains char-
acterized by the production of one or more Shiga toxins (stx1,
stx2, or their variants). STEC is common in ruminants and
related foods (4, 5, 15, 30, 47). Clinical manifestations in hu-
mans range from hemorrhagic colitis (HC) to hemolytic ure-
mic syndrome (HUS) and thrombocytopenic purpura (TTP)
(3) and are directly related to the virulence genes present in
the causative agent. To date, STEC prevalence studies have
focused primarily on E. coli O157:H7, because of its initial
predominance in human clinical infection. Culture and molec-
ular methods for the detection of STEC have thus been devel-
oped and optimized for that serotype, with little attention to
and resultant underestimation of the risks posed by non-O157
serogroups. However, non-O157 infections are of primary con-
cern in several countries (19), with half of all confirmed STEC
infections in Europe caused by non-O157 STEC (3), and non-
O157 infections outnumber O157 cases in the United States
(10). Ireland has the highest per capita incidence (5.7 STEC
cases per 100,000) in Europe (28).
E. coli O157:H7, the most extensively investigated serotype,
has long been associated with ruminants, but more-recent work
has suggested that these animals are also important reservoirs
for other STEC serotypes (29). Six non-O157 O groups have
been identified by the Centers for Disease Control and Pre-
vention (CDC) as being responsible for over 70% of non-O157
STEC-associated illness (O26, O45, O103, O111, O121, and
O145) (10), and both the European Food Safety Authority
(EFSA) and the U.S. Department of Agriculture (USDA)
have issued recommendations for laboratory testing for these
pathogens (17, 19). However, serotype alone does not neces-
sarily provide an accurate assessment of the ability to cause
illness or the severity of disease, which requires virulence gene
data. In addition to the stx genes, other virulence factors en-
coded by eaeA (intimin), tir (espE) (translocated intimin recep-
tor), espA (EspA protein), and espB (EspB protein) are re-
quired for intimate attachment and the formation of the
attaching and effacing (A/E) lesions characteristic of STEC
infection (10, 13, 79). Other clinically significant virulence
markers include hlyA (pO157 enterohemolysin releasing he-
moglobin from red blood cells), katP (pO157 catalase peroxi-
dase that defends the cell against oxidative damage), etpD
(pO157, encodes part of a type II secretory pathway transport-
ing proteins across the outer membrane) (73), lpf (chromo-
somal long polar fimbriae) (72), espP (pO157 extracellular
serine protease autotransporter), saa (pO113 STEC aggluti-
nating adhesion) (55), sab (pO113 STEC autotransporter)
(33), toxB (pO157 adhesion), and iha (chromosomal iron-reg-
ulated gene A homolog adhesin) (68, 70).
Despite the increasing general recognition of the clinical
significance of non-O157 STEC, there is a lack of data on (i)
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prevalence at the farm level, (ii) distribution of virulence fac-
tors, and (iii) emerging serotypes for inclusion in future mon-
itoring programs. The objective of this study was to contribute
to addressing these data gaps. Furthermore, as the interaction
between different virulence gene products in pathogenesis is
poorly understood, the presence of virulence genes in farm
serotypes in this study that are not associated with human
infection would also provide an important insight into the
relative importance of virulence factors required for human
illness.
MATERIALS AND METHODS
Sample collection. Twenty bovine (beef and dairy) farms located throughout
the Republic of Ireland were selected on the basis of geographical location
(covering the whole country) for inclusion in this study. Each farm was sampled
bimonthly over a 1-year period (July 2007 to July 2008). Animals were largely on
pasture for the duration of the study, although they were housed during the
winter months. At each visit, 10 fresh fecal samples (from the ground) and 5 soil
samples (taken from areas where the animals congregated, such as beside a water
trough) were aseptically transferred into sterile containers (Sterilin Ltd., Medical
Supply Co., Mulhuddard, Dublin, Ireland). A total of 1,200 fecal and 600 soil
samples were taken throughout the study. Samples were stored at 4°C for no
more than 24 h prior to analysis.
Bacterial cultures. The E. coli control strains used are described in Table 1.
Control strains used in the typing of the Shiga toxin genes, STEC strain
O111:H (EC132) and STEC strain O113:H21 (98NK2), were kindly provided
by Helge Karch (University of Mu¨nster, Germany) and Adrienne Patton (Uni-
versity of Adelaide, Australia), respectively.
Detection of vt-positive E. coli. Each sample (10 g) was homogenized with 90
ml of tryptone soya broth (TSB; CM0129; Oxoid, Basingstoke, United Kingdom)
containing 4 g ml1 vancomycin hydrochloride (V2002; Sigma-Aldrich, St.
Louis, MO) and incubated overnight at 37°C. One-milliliter aliquots of the
homogenized enrichment were harvested by centrifugation (7,426  g for 10 min
at 4°C). Genomic DNA was extracted from the resultant pellets (resuspended in
maximum-recovery diluent [MRD] CM0733; Oxoid, Basingstoke, United King-
dom) by using the DNeasy tissue kit (69506; Qiagen, Crawley, United Kingdom)
according to the manufacturer’s instructions. The remainder of the enrichment
samples were stored at 4°C. The sample DNA (2 l) was screened for the
presence of stx1 and/or stx2 genes by using PCR in a Peltier thermal cycler
(PTC-200; MJ Research Inc., Watertown, MA) with primer sets and reaction
conditions as described by Paton and Paton (54) (Table 2). The reaction mixture
(reaction mix A) was modified by using 1 Green GoTaq reaction buffer (M891;
Promega, Madison, WI) and made up to a final volume of 25 l. PCR products
(10 l) were separated by electrophoresis on a 1.5% (wt/vol) agarose gel and
visualized under UV light (GelDoc 2000 system; Bio-Rad Laboratories, Hercu-
les, CA) by ethidium bromide staining (10 mg ml1). Product size was deter-
mined using a BenchTop 100-bp DNA ladder (G8291; Promega).
Isolation of stx-positive E. coli. Samples positive for the virulence genes stx1
and/or stx2 were serially diluted in MRD and plated onto Chromocult tryptone
bile X-glucuronide agar (TBX; Merck, Germany) supplemented with sterile
filtered streptomycin sulfate (10 g ml1) (S6501; Sigma-Aldrich, Steinheim,
Germany) and sulfamethazine (100 g ml1) (S6256; Sigma-Aldrich, Steinheim,
Germany). Preliminary studies in our laboratory (data not shown), designed to
optimize non-O157 recovery, found that TBX agar gave maximum recovery of
non-O157 STEC isolates. After overnight incubation at 37°C, 5 colonies of
differing colony morphologies were taken from each sample and streaked onto
nutrient agar (NA) (CM0003; Oxoid, Basingstoke, United Kingdom) and eosin
methylene blue agar (EMBA) (CM0069; Oxoid, Basingstoke, United Kingdom).
Agar plates were incubated overnight at 37°C. Genomic DNA was extracted
from presumptive E. coli colonies (those showing a green sheen on EMB plates)
by resuspending a single colony from the NA plate in PrepMan Ultra sample
preparation reagent (Applied Biosciences, Foster City, CA) and extracting DNA
as per the manufacturer’s instructions. All isolates were assessed for the presence
of stx1, stx2, eaeA, and enterohemorrhagic E. coli (EHEC) hlyA by using 2 l of
the DNA sample and the PCR protocol as described above (Table 2). All STEC
isolates were preserved in a cryogenic bead storage system (Protect bacterial
preservers; TSC Ltd., Heywood, United Kingdom) at 20°C and were routinely
recultured.
Serotyping. Serotyping of the O (lipopolysaccharide) and H (flagellar) anti-
gens was performed by the E. coli Reference Center at Pennsylvania State
University, University Park, PA. The O antigen was determined using antisera
produced against available serogroups designated O1 to O181, with the excep-
tions of O31, O47, O72, O93, O94, and O122, as these are not designated (52).
The H antigen was established by PCR-restriction fragment length polymor-
phism (PCR-RFLP) analysis of the fliC gene, which is responsible for flagella
(46).
Detection of putative virulence and adhesion genes. One cryogenic bead of
each STEC isolate was individually cultured in 10 ml of TSB overnight at 37°C.
Genomic DNA was extracted from a 1-ml aliquot of culture by using PrepMan
Ultra reagent. In addition to stx1, stx2, eaeA, and hlyA genes, the template DNA
of each STEC isolate was analyzed using PCR for the presence or absence of
other putative virulence and adhesion genes. These include (i) genes associated
with the locus of enterocyte effacement (LEE) (tir, espA, and espB), (ii) plasmid-
encoding virulence genes associated with STEC O157:H7 (katP, espP, and etpD),
and (iii) genes encoding other attachment mechanisms (saa, sab, toxB, iha,
lpfAO157/OI-141, lpfAO113, and lpfAO157/OI-154). The primer sets and target genes
used in these analyses are also listed in Table 2. Reaction mixture A was used
to amplify the katP, etpD, tir, saa, toxB, iha, lpfAO157/OI-141, lpfAO113, and
lpfAO157/OI-154 genes. Reaction mixture B was modified from the method of
McNally et al. (48), in which 1 Green GoTaq reaction buffer was used to
amplify the espA, espB, espP, and sab genes. Reaction mixtures, including 2 l of
DNA, were made up to a final volume of 25 l, and PCR product (10 l) was
separated by electrophoresis on a 1.5% (wt/vol) agarose gel and visualized under
UV light by ethidium bromide staining. Product size was determined using a
BenchTop 100-bp DNA ladder.
Molecular characterization of stx variants. The Shiga toxin genes were sub-
typed using the primer sets, typing protocols, and PCR conditions given in Table
2. Briefly, isolates were initially examined by PCR using the primer pair KS7 and
KS8 to detect stx1 and the genetic variants (stx1c and stx1d) of stx1 (66). Positive
isolates were further assessed for the presence of vt1c and vt1d by using the primer
pair stx1c-1 and stx1c-2 (77) and primer pair VT1AvarF and VT1varR (12). PCR
and RFLP-PCR was used to examine each isolate for the presence of vt2 and its
genetic variants (stx2a, stx2c, activatable stx2d [stx2dact], stx2e, stx2f, and stx2g) by
TABLE 1. Origin and serotype of isolates used as positive controls
Strain Serotype Origin Target gene Reference/source
3653/97 O78:H Patient with diarrhea stx1c 77
7139/96 O8:H Asymptomatic carrier stx1d 42
E32511 O157:H Patient with HC stx2c 34
EH250 ONT:H12 Patient with diarrhea stx2d (nonactivatable) 61
B2F1 O91:H21 Patient with HUS stx2dact 49
2771/97 ONT: H Patient with diarrhea stx2e 50
T4/97 O128:H2 Pigeon stx2f 67
EC132 O111:H Bovine feces stx1, stx2, eaeA, and hlyA Provided by University of
Mu¨nster, Germany
98NK2 O113:H21 Patient with HUS lpfAO113, saa, sab 56
38094 O157:H7 Patient with HUS katP, etpD, tir, espP, espA, espB,
lpfAO157/OI154, toxB, and iha
Provided by CDC,
Atlanta, GA
C9490 O157:H7 Patient with HUS lpfA 74
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using previously published methods (Table 2). In brief, all STEC isolates were
examined by PCR with the primer pair LP43 and LP44 for the detection of stx2,
stx2c, stx2dact, and stx2e (13); primer pair 128-1 and 128-2 for the detection of vt2f
(67); and primer pair 209F and 781R for the detection of vt2g (44). Isolates
positive for stx2 were further differentiated by PCR screening using the primer
pair GK3 and GK4 (32) to detect stx2, stx2c, and stx2dact. The resulting PCR
products were incubated with the HaeIII restriction enzyme (R0107; New Eng-
land BioLabs, Hertfordshire, United Kingdom) according to the manufacturer’s
instructions. Bands at 137 bp and 151 bp (32) indicated the presence of the
variant stx2c or stx2dact. PCR-RFLP methods were also used to differentiate
between stx2c and stx2dact. PCR was preformed using the primer pair SLT-II-vc
and CKS2. The resulting PCR product (890 bp) was incubated in the PstI
TABLE 2. Target genes and primer sequences used for the detection of STEC virulence gene markers
Primer Sequence (5–3) Target (gene) Reference
stx1-F ATAAATCGCCATTCGTTGACTAC stxA1 54
stx1-R AGAACGCCCACTGAGATCATC
stx2-F GGCACTGTCTGAAACTGCTCC stxA2 54
stx2-R TCGCCAGTTATCTGACATTCTG
eaeA-F GACCCGGCACAAGCATAAGC eaeA 54
eaeA-R CCACCTGCAGCAACAAGAGG
hlyA-F GCATCATCAAGCGTACGTTCC hlyA 54
hlyA-R AATGAGCCAAGCTGGTTAAGCT
TIR-F CATTACCTTCACAAACCGAC tir 40
TIR-R CCCCGTTAATCCTCCCAT
EspAa CACGTCTTGAGGAAGTTTGG espA 48
EspAb CCGTTGTTAATGTGAGTGCG
EspBa CGATGGTTAATTCCGCTTCG espB 48
EspBb CGATGGTTAATTCCGCTTCG
ESPPa AAACAGCAGGCACTTGAACG espP 48
ESPPb AGACAGTTCCAGCGACAACC
D1 CGTCAGGAGGATGTTCAG etpD 65
D13R CGACTGCACCTGTTCCTGATTA
wkat-B CTTCCTGTTCTGATTCTTCTGG katP 11
wkat-F AACTTATTTCTCGCATCATCC
lpfO141-F CTGCGCATTGCCGTAAC lpfAO157/OI-141 69
lpfO141-R ATTTACAGGCGAGATCGTG
lpfA-F ATGAAGCGTAATATTATAG lpfAO113 16
lpfA-R TTATTTCTTATATTCGAC
O154-FCT GCAGGTCACCTACAGGCGGC lpfAO157/OI-154 71
O154-RCT CTGCGAGTCGGCGTTAGCTG
SAADF CGTGATGAACAGGCTATTGC saa 55
SAADR ATGGACATGCCTGTGGCAAC
toxB.911F ATACCTACCTGCTCTGGATTGA toxB 70
toxB.1468R TTCTTACCTGATCTGATGCAGC
iha-I CAGTTCAGTTTCGCATTCACC iha 68
iha-II GTATGGCTCTGATGCGATG
LH0147-BamHI CCCGGATCCGGAAACTCCAAGAGTATTGC sab 33
LH0147-EcoRI CCCGAATTCCCTTGCTTTTCCCTGTTACC
KS7 CCCGGATCCATGAAAAAAACATTATTAATAGC stx1b 66
KS8 CCCGAATTCAGCTATTCTGAGTCAACG
Stx1c-1 TTTTCACATGTTACCTTTCCT stxA1c 77
Stx1c-2 CATAGAAGGAAACTCATTAGG
VT1varF CTTTTCAGTTAATGCGATTGCT stxA1d 12
VT1varR AACCCCATGATATCGACTGC
LP43 ATCCTATTCCCGGGAGTTTACG stxA2 variants 13
LP44 GCGTCATCGTATACACAGGAGC
GK3 ATGAAGAAGATGTTTATG stxB2 and stxB2c 32
GK4 TCAGTCATTATTAAACTG
SLT-II-vc ACCACTCTGCAACGTGTCGC stx2c and stx2dact 36
CKS2 ACTGAATTGTGACACAGATTA
VT2-cm AAGAAGATATTTGTAGCGG stxB2d 61
VT2-f TAAACTGCACTTCAGCAAAT
FK1 CCCGGATCCAAGAAGATGTTTATAG stxB2e 21
FK2 CCCGAATTCTCAGTTAAACTTCACC
128-1 AGATTGGGCGTCATTCACTGGTTG stxA2f 67
128-2 TACTTTAATGGCCGCCCTGTCTCC
209F GTTATATTTCTGTGGATATC stx2g 44
781R GAATAACCGCTACAGTA
VSAAF ACTCGCATAATTGGTGGTG saa variants 45
VSAAR ATCATTGGTATTGCTGTCAT
EaeVF AGYATTACTGAGATTAAG eae variants 64
EaeVR AAATTATTYTACACARAY
EaeZetaVR AGTTTATTTTACGCAAGT
EaeIotaVR TTAAATTATTTTATGCAAAC
8664 MONAGHAN ET AL. APPL. ENVIRON. MICROBIOL.
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restriction enzyme (R0140; New England BioLabs) according to the manufac-
turer’s instructions. The absence of any band in the amplicon was indicative of
stx2dact, with 504-bp and 386-bp bands indicative of stx2 and stx2c, respectively
(36).
Molecular characterization of intimin variants. All intimin-positive STEC
isolates were further characterized using intimin typing as described by Ram-
achandran and colleagues (64). Briefly, a single forward primer (EaeVF) and 3
reverse primers (EaeVR, EaeZetaVR, and EaeIotaVR) (Eurofins MWG
Operon, Ebersberg, Germany) (Table 2) were used to amplify an 834- to 876-bp
fragment (size varied depending on the variant) representing the 3-variable
regions of all reported intimin variants. The resulting PCR products (10 l) were
incubated along with 3 restriction endonucleases, AluI, RsaI, and CfoI (New
England Biosciences, Ipswich, MA), following the manufacturer’s instructions.
The restriction fragments were separated by agarose gel electrophoresis and
visualized using ethidium bromide staining. To determine which intimin type was
present in each isolate, the resulting RFLP patterns were compared to published
RFLP profiles (64).
Sequencing analysis. All PCR products for the intimin variants and the vt2g
gene were purified using the QIAquick PCR purification kit (28106; Qiagen,
Crawley, West Sussex, United Kingdom) by following the manufacturer’s guide-
lines and commercially sequenced (Eurofins MWG Operon, Ebersberg, Ger-
many). Sequences were analyzed using the BLASTN program to search nucle-
otide databases (2), and sequences were aligned with the sequence of the vt2g
gene and intimin variants.
RESULTS
Of the 1,800 samples analyzed, 40% (480/1,200) of fecal and
27% (162/600) of soil samples were stx1 and/or stx2 positive.
STEC were cultured from 1.9% (23/1,200) of fecal and 0.7%
(4/600) of soil samples, with the majority of the 107 isolates
obtained from samples taken from May to September (Fig. 1).
The serotypes obtained included O2:H27, O6:H8, O13/O150:
H2, O20:H19, O26:H11, O86:H21, O109:H5, O113:H4, O116:
H28, O119:H5, O136:H2, O136:H16, O145:H28, O168:H8,
O168:H27, O171:H2, and O174:H21 (Table 3). There were 6
isolates which could not be assigned to O-antigen serogroups
but had H4, H17, H18, or H27 flagellar antigens. The most
frequently occurring serotypes were O113:H4 (29%), O26:H11
(13%), and O2:H27 (12%), and the most widely distributed
were O26:H11 (5 farms) and O113:H4 (4 farms).
stx1, stx2, and a combination of both were present in 22%,
42%, and 36% of isolates, respectively. The stx1c and stx1d gene
variants were not detected, but stx2d, stx2dact, and stx2g were
present in 77%, 11.2%, and 8.4% of isolates, respectively. The
distribution of target virulence genes in the farm isolates is
shown in Table 3. The intimin gene (eaeA) was present in 18%
of isolates: serotypes O2:H27 (variant untypeable), O13/
O150:H2 (), O26:H11 (1), O145:H28 (), and ONT:H27 ().
Other virulence genes detected included hlyA (26%; O2:H27,
O13/O150:H2, O20:H19, and O26:H11), tir (14%; O2:H27,
O26:H11, and O145:H28), espA (0.9%; O145:H28), espB
(0.9%; O145:H28), lpfO157/OI-141 (10.3%; O109:H5, O119:H5,
O145:H28, and ONT:H4), lpfAO113 (48.5%; O2:H27, O6:H8,
O13/O150:H2, O20:H19, O26:H11, O86:H21, O109:H5, O116:
H28, O136:H2, O136:H16, O168:H8, O168:H27, O171:H2,
O174:H21, ONT:H4, and ONT:H18), espP (23%; O2:H27,
O13/O150:H2, O20:H19, O26:H11, O86:H21, O116:H28,
O136:H2, O136:H16, O168:H8, O168:H27, O171:H2, O174:
H21, ONT:H4, and ONT:H18), saa (5.6%; O20:H19, O86:
H21, ONT:H4, and ONT:H18), toxB (15.9%; O2:H27, O26:
H11, and O145:H28), and iha (73.8%; O2:H27, O6:H8, O13/
O150:H2, O20:H19, O26:H11, O86:H21, O109:H5, O113:H4,
O145:H28, O168:H8, O168:H27, O171:H2, O174:H21, ONT:
H4, ONT:H17, and ONT:H18). Virulence genes katP, etpD,
lpfAO157/OI-154, and sab were not detected in any of the isolates.
Interestingly, different virulence gene profiles were detected
within strains from the same serotype; for example, O26:H11
(10 isolates) displayed 3 different virulence profiles: stx1 stx2
stx2d eaeA hlyA tir lpfAO113 espP toxB iha (7 isolates), stx1 eaeA
hlyA tir lpfAO113 espP toxB iha (2 isolates), and stx1 eaeA hlyA
lpfAO113 espP toxB iha (1 isolate).
DISCUSSION
Forty percent of bovine fecal and 27% of farm soil samples
were positive for Shiga toxin genes (stx1 and/or stx2), with
culture-based prevalences of 1.9% and 0.7%, respectively. The
difference in the molecular and culture-based analyses was
attributed to the relative sensitivities of the two methods and
the presence of phage DNA. The increased prevalence in late
summer-early autumn has been widely reported (38, 60, 62)
and corresponds to an increase in human cases for both O157
and non-O157 STEC (31).
Seventeen different serotypes were isolated from bovine fe-
ces and beef farm soil samples, including O2:H27, O6:H8,
FIG. 1. The seasonal distribution of STEC-positive enrichment samples in feces (f) and soil ().
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O13/O150:H2, O20:H19, O26:H11, O86:H21, O109:H5, O113:
H4, O116:H28, O119:H5, O136:H2, O136:H16, O145:H28,
O168:H8, O168:H27, O171:H2, and O174:H21. Of these, O20:
H19, O26:H11 O113:H4, and O171:H2 are common in cattle
(7). Indeed the most prevalent serogroup in our study, O113, is
the predominant serogroup reported in the majority of Euro-
pean bovine surveys (79). However, our study also discovered
a range of new serotypes (O6:H8, O13/O150:H2, O86:H21,
O109:H5, O116, H28, O119:H5, and ONT:H17) not previously
reported in the lists of non-O157 strains previously published
(8, 35, 79). Furthermore, 6 of the 107 STEC strains were O
nontypeable, highlighting the need for new antisera for the
detection of emerging STEC serogroups. In total, 55% of the
strains belonged to 5 serotypes (O2:H27, O26:H11, O113:H4,
O136:H2, and O174:H21) previously associated with disease in
humans. Moreover, the second most prevalent serotype (O26:
H11) has been widely associated with HUS.
STEC strains from patients suffering severe disease such as
HC or HUS are frequently stx2 and eaeA positive and many
also carry the hlyA gene (23). The majority of the strains
obtained in this study were stx2 positive, with 77% of isolates
carrying the stx2 and stx2d variants, 13% stx2dact, and 8% stx2g.
A high prevalence of stx2 genes in bovine STEC has been
previously reported (6, 10), in particular stx2, stx2d, and stx2g
(78). In more general terms, the high incidence of stx2 genes
observed in this and other studies is a matter of some concern,
as the carriage of stx2 genes and in particular stx2c and stx2dact
has been linked to more-severe E. coli infection (25), and the
presence of stx2c and stx2dact in O168:H8, O171:H2, and ONT:
H18 is of particular concern, as all three serotypes, while
eaeA negative, possessed an alternative attaching mecha-
nism (lpfAO113).
stx1 was present in 11% of isolates, but neither stx1c nor stx1d
was detected. STEC strains harboring stx1c or stx1d are more
commonly associated with ovine sources (41) and are rarely
recovered from patients suffering from HC or HUS (23, 24).
The eaeA gene was detected in less than one-fifth of isolates
(18/107), a finding consistent with previous studies which re-
ported a lower frequency in bovine than in human strains (8).
Intimin-positive serotypes included O2:H27, O13/O150:H2,
O26:H11, and O145:H28 as well as ONT:H27, with the O26:
H11 strains carrying type 1. This subtype has been previously
associated with O26:H11 and O157:H7 (8, 64), and its high
specificity for both bovine and human cells may underlie its
association with clinically significant STEC (9). O145:H2 and
ONT:H27 strains carried intimin  and , respectively, which
along with 1 are commonly recovered from HC and HUS
outbreak patients (53, 64). Different intimin types may have
different host cell tropisms (73), and differentiation of different
intimin alleles is an important diagnostic and epidemiological
tool. The O2:H27 intimin variant was untypeable, suggesting
there are more subtypes yet to be identified and characterized.
With the exception of those mentioned above, most STEC
serotypes were eaeA negative and therefore unlikely to be
associated with large outbreaks and HUS (39), a situation
previously reported for the majority of bovine STEC (75, 76).
However, while there is a strong association between the car-
riage of eaeA and the capacity to cause severe human disease
(14), non-eaeA strains have been responsible for sporadic cases
and small outbreaks in both the United States and Australia
(20, 59) as well as the recent outbreak associated with intimin-
negative O104:H4 in Germany (18). Attachment of eaeA-neg-
ative human pathogenic strains is therefore mediated by alter-
native adherence factors such as the STEC autoagglutinating
TABLE 3. Serotypes, sources (fecal or soil), number of isolates, virulence factors, and variantsa
Serotype (source) No. ofisolates stx1 stx1c stx1d stx2 stx2c stx2dact stx2d stx2e stx2f stx2g eaeA hlyA tir espA espB lpfAO157 lpfAO113 espP saa toxB iha
O2:H27 (1F) 1 	          	 (NT) 	 	    	 	
O2:H27 (2F) 2    	   	     	        	 	
O2:H27 (2F) 2    	   	     	         	
O2:H27 (2F, 1S) 3    	   	              
O2:H27 (4F, 4S) 5    	   	     	         
O6:H8 (1S) 1 	                	    	
O13/O150:H2 (2F) 2 	   	   	    	 () 	     	 	   	
O20:H19 (1F) 1 	   	   	     	     	 	 	  	
O26:H11 (6F) 6 	          	 (1) 	 	    	 	  	 	
O26:H11 (7F) 7 	   	   	    	 (1) 	 	    	 	  	 	
O26:H11 (1S) 1 	          	 (1) 	     	 	  	 	
O86:H21 (1F) 1    	   	          	 	 	  	
O109:H5 (1F) 1 	               	     	
O113:H4 (3S, 23F) 26 	   	   	              	
O113:H4 (3F) 3    	   	              	
O113:H4 (1S, 1F) 2 	   	   	              
O116:H28 (4F, 2S) 6    	   	   	       	    
O119:H5 (3F, 3S) 6 	               	     
O136:H2 (1F) 1    	   	   	       	    
O136:H16 (2F) 2    	   	   	       	    
O145:H28 (1F) 1 	          	 ()  	 	 	 	  	  	 	
O168:H8 (7F) 7    	  	 	          	    	
O168:H8 (2F) 2 	                	    	
O168:H27 (F) 1 	                	    	
O171:H2 (4F) 4    	  	 	          	    	
O174:H21 (7F) 7    	   	          	    	
ONT:H4 (3F, 1S) 3 	               	  	 	  	
ONT:H17 (1S) 1 	                    
ONT:H18 (1F) 1    	   	     	     	 	 	  	
ONT:H27 (1F) 1 	          	 ()       	 	  
a F, fecal sample; S, soil sample. Numbers of samples from each source are also indicated. NT, nontypeable.
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adhesion (Saa), found in 5.6% of the strains in this study.
Furthermore, to the best of our knowledge, this is the first
study reporting the presence of saa in serotypes O20:H19,
O86:H21, ONT:H4, and ONT:H18. All of the saa-positive
strains were eaeA negative, supporting the hypothesis that
these virulence factors are mutually exclusive (1, 37, 43, 58, 71,
78, 79). The eaeA gene is located in the LEE region of the
chromosome, while the saa gene is found on pO113; thus there
is no known reason as to why both could not be present in the
same STEC strain. Further research is required.
The hemolysin gene, hlyA, was present in 30% of our strains,
while the etpD and katP genes were absent in all isolates,
despite all 3 genes being carried on pO157. Several studies
have shown that these 3 genes are almost always present in
O157:H7 but occur sporadically in non-O157 strains (22). In-
deed, the etpD gene is rarely detected in bovine STEC (22). All
of the O113:H4 (the most prevalent serotype) isolates were
eaeA negative, a characteristic particularly associated with the
O113 serogroup (57). In recent years, intimin-negative STEC
O113:H4 has been associated with clinical cases in Ireland (26,
27). Intimin-negative O113:H4 has also been implicated in
sporadic cases in other countries, where patients displayed an
array of symptoms, including colitis and watery diarrhea (63).
Conclusion. Despite the low prevalence of STEC using cul-
ture-based methods, the diversity of serotypes provides further
evidence that cattle are an important reservoir of STEC. The
isolation of eaeA-positive O2:H27, O13/O150:H2 O26:H11,
O145:H28, and ONT:H27 represents a risk to public health, as
does the presence of phage-mediated HUS-associated stx2dact
genes in 6% of our isolates. Moreover, cattle are also an
important source of atypical STEC, with this study reporting
several previously unknown saa-positive STEC serotypes. Our
work also highlights several knowledge gaps, including the
limitation of current intimin typing and O-serotyping methods
as well as in our understanding of virulence factors, specifically
why eaeA and saa are rarely if ever found in the same strains.
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